These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24957772)

  • 21. Gastric metaplasia of the proximal esophagus associated with esophageal adenocarcinoma and Barrett's esophagus: what is the connection? Inlet patch revisited.
    Malhi-Chowla N; Ringley RK; Wolfsen HC
    Dig Dis; 2000; 18(3):183-5. PubMed ID: 11279338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic features of buried Barrett's mucosa.
    Yang LS; Holt BA; Williams R; Norris R; Tsoi E; Cameron G; Desmond P; Taylor ACF
    Gastrointest Endosc; 2021 Jul; 94(1):14-21. PubMed ID: 33373645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts.
    Hoefnagel SJM; Mostafavi N; Timmer MR; Lau CT; Meijer SL; Wang KK; Krishnadath KK
    PLoS One; 2020; 15(4):e0231419. PubMed ID: 32282835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center.
    Kaul V; Bittner K; Ullah A; Kothari S
    Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31909783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Origins of Metaplasia in Barrett's Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease?
    Zhang W; Wang DH
    Dig Dis Sci; 2018 Aug; 63(8):2005-2012. PubMed ID: 29675663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deoxycholic acid impairs glycosylation and fucosylation processes in esophageal epithelial cells.
    Byrne AM; Sharma R; Duggan G; Kelleher D; Long A
    Glycobiology; 2012 May; 22(5):638-48. PubMed ID: 22223758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study.
    Ross-Innes CS; Chettouh H; Achilleos A; Galeano-Dalmau N; Debiram-Beecham I; MacRae S; Fessas P; Walker E; Varghese S; Evan T; Lao-Sirieix PS; O'Donovan M; Malhotra S; Novelli M; Disep B; Kaye PV; Lovat LB; Haidry R; Griffin M; Ragunath K; Bhandari P; Haycock A; Morris D; Attwood S; Dhar A; Rees C; Rutter MD; Ostler R; Aigret B; Sasieni PD; Fitzgerald RC;
    Lancet Gastroenterol Hepatol; 2017 Jan; 2(1):23-31. PubMed ID: 28404010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus exposure and sexual behavior are significant risk factors for Barrett's dysplasia/esophageal adenocarcinoma.
    Wong MYW; Wang B; Yang A; Khor A; Xuan W; Rajendra S
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29931323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.
    Grant KS; DeMeester SR; Kreger V; Oh D; Hagen JA; Chandrasoma P; DeMeester TR
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):31-7. PubMed ID: 23312980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence.
    O'Farrell NJ; Feighery R; Picardo SL; Lynam-Lennon N; Biniecka M; McGarrigle SA; Phelan JJ; MacCarthy F; O'Toole D; Fox EJ; Ravi N; Reynolds JV; O'Sullivan J
    BMC Cancer; 2016 Jul; 16():497. PubMed ID: 27431913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversies in Barrett's esophagus: management of high grade dysplasia.
    Sharma P
    Semin Gastrointest Dis; 2001 Jan; 12(1):26-32. PubMed ID: 11215852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence.
    Lord RV; Tsai PI; Danenberg KD; Peters JH; Demeester TR; Tsao-Wei DD; Groshen S; Salonga D; Park JM; Crookes PF; Kiyabu M; Chandrasoma P; Danenberg PV
    Surgery; 2001 Mar; 129(3):267-76. PubMed ID: 11231454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Brabender J; Lord RV; Wickramasinghe K; Metzger R; Schneider PM; Park JM; Hölscher AH; DeMeester TR; Danenberg KD; Danenberg PV
    J Gastrointest Surg; 2002; 6(3):359-67. PubMed ID: 12022988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
    Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
    Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
    Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
    Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Overholt BF; Sampliner RE; Wolfsen HC; Wang KK; Fleischer DE; Sharma VK; Eisen GM; Fennerty MB; Hunter JG; Bronner MP; Goldblum JR; Bennett AE; Mashimo H; Rothstein RI; Gordon SR; Edmundowicz SA; Madanick RD; Peery AF; Muthusamy VR; Chang KJ; Kimmey MB; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Dumot JA; Falk GW; Galanko JA; Jobe BA; Hawes RH; Hoffman BJ; Sharma P; Chak A; Lightdale CJ
    Gastroenterology; 2011 Aug; 141(2):460-8. PubMed ID: 21679712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence.
    Davelaar AL; Straub D; Buttar NS; Fockens P; Krishnadath KK
    Scand J Gastroenterol; 2015 Mar; 50(3):321-32. PubMed ID: 25562781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant progression in Barrett's esophagus: pathology and molecular biology.
    Mueller J; Werner M; Siewert JR
    Recent Results Cancer Res; 2000; 155():29-41. PubMed ID: 10693236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.